Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Loza

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Scientific Reports|October 3, 2024
Pharmacodynamic, prognostic, and predictive biomarkers in severe and critical COVID-19 patients treated with sirukumabKim Thys, Matthew J Loza, Linghua Lynn, et al.
Therapeutic Advances in Musculoskeletal Disease|October 28, 2025
Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multiple-dose phase Ib studyIrving T C Ling, Stanley J Marciniak, Stephen H Clarke, et al.
ERJ Open Research|December 28, 2023
Using an electronic diary and wristband accelerometer to detect exacerbations and activity levels in COPD: a feasibility studyLydia J Finney, Stefan Avey, Dexter Wiseman, et al.
Respiratory Research|December 17, 2016
Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT studyMatthew J Loza, Ratko Djukanovic, Kian Fan Chung, et al.
The Prostate|November 28, 2008
Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancerYu Cheng, Jin Woo Kim, Wennuan Liu, et al.
Clinical and Vaccine Immunology : CVI|April 22, 2011
Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosisMatthew J Loza, Carrie Brodmerkel, Roland M Du Bois, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2019
Combined Blockade of TNF-α and IL-17A Alleviates Progression of Collagen-Induced Arthritis without Causing Serious Infections in MiceFang Shen, Akash H Verma, Amy Volk, et al.
Plos One|November 12, 2019
The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitisCarl L Manthey, Beverley A Moore, Yanqing Chen, et al.
Rheumatology and Therapy|March 30, 2022
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)Georg Schett, Matthew J Loza, Arumugam Palanichamy, et al.
Biomarker Insights|September 30, 2017
Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow LimitationPhilip E Silkoff, Dave Singh, J Mark FitzGerald, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Scientific Reports|October 3, 2024
Pharmacodynamic, prognostic, and predictive biomarkers in severe and critical COVID-19 patients treated with sirukumabKim Thys, Matthew J Loza, Linghua Lynn, et al.
Therapeutic Advances in Musculoskeletal Disease|October 28, 2025
Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multiple-dose phase Ib studyIrving T C Ling, Stanley J Marciniak, Stephen H Clarke, et al.
ERJ Open Research|December 28, 2023
Using an electronic diary and wristband accelerometer to detect exacerbations and activity levels in COPD: a feasibility studyLydia J Finney, Stefan Avey, Dexter Wiseman, et al.
Respiratory Research|December 17, 2016
Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT studyMatthew J Loza, Ratko Djukanovic, Kian Fan Chung, et al.
The Prostate|November 28, 2008
Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancerYu Cheng, Jin Woo Kim, Wennuan Liu, et al.
Clinical and Vaccine Immunology : CVI|April 22, 2011
Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosisMatthew J Loza, Carrie Brodmerkel, Roland M Du Bois, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2019
Combined Blockade of TNF-α and IL-17A Alleviates Progression of Collagen-Induced Arthritis without Causing Serious Infections in MiceFang Shen, Akash H Verma, Amy Volk, et al.
Plos One|November 12, 2019
The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitisCarl L Manthey, Beverley A Moore, Yanqing Chen, et al.
Rheumatology and Therapy|March 30, 2022
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)Georg Schett, Matthew J Loza, Arumugam Palanichamy, et al.
Biomarker Insights|September 30, 2017
Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow LimitationPhilip E Silkoff, Dave Singh, J Mark FitzGerald, et al.
Pageof 6